Lixte Biotechnology Holdings Inc【LIXT】株式ニュース

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

The New Bottleneck Isn’t Computing Power — It’s Just Power

Issued on behalf of LIXTE Biotechnology Holdings, Inc. America can build data centers in months, but the...

From Cancer Drugs to Kilowatts: A NASDAQ Company's Bet on the AI Power Crunch

From Cancer Drugs to Kilowatts: A NASDAQ Company's Bet on the AI Power Crunch PR Newswire BOCA RATON, Fla...

LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS)

Company to be Renamed NOMAD Power Solutions • First-to-Market with the Mobile, Utility-Grade 1 MW BESS •...

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

LIXTE Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth

Announcement Follows the Recent Appointment of Denham Capital Founder Stuart D. Porter — a Three-Decade Energy...

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors

Bringing More Than Three Decades of Energy Investment Experience, Mr. Porter Has Helped Build a Global Power...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 4 - Statement of changes in beneficial ownership of securities

LIXT...$5.04...🥳...Off my $4 Alert...

georgie18

Member Level
Re: georgie18 post# 397942

Tuesday, September 09, 2025 1:43:06 PM

Post#
397963
of 397966
LIXT...$4.90...🥳...Hod...

georgie18

Member Level
Re: georgie18 post# 696691

Tuesday, September 09, 2025 11:18:37 AM

Post#
697371
of 697419
LIXT...$4.728...🥳...Hod off my $4 Alert...

georgie18

Member Level
Re: georgie18 post# 397733

Thursday, September 04, 2025 7:51:01 AM

Post#
397742
of 397941
LIXT...$4.67...🥳

georgie18

Member Level
Re: georgie18 post# 696310

Wednesday, September 03, 2025 3:56:59 PM

Post#
696636
of 696690
LIXT...$4.60...🥳...Lets see if we het the Doubl;e Top Breakout here and a run at $5 plus...

georgie18

Member Level
Re: georgie18 post# 397600

Friday, August 29, 2025 11:40:34 AM

Post#
397602
of 397733
LIXT...$4.44...🥳...Looking for $5 Break...

georgie18

Member Level
Re: georgie18 post# 696242

Friday, August 29, 2025 11:18:44 AM

Post#
696306
of 696309
LIXT...$4.32...🥳...Looking for $5 Breakout...

georgie18

Member Level
Re: None

Friday, August 29, 2025 8:18:46 AM

Post#
397578
of 397599
LIXT...$4.00...🥳... https://schrts.co/GKZFBTSZ ...Looking for $5 Breakout...imo...we shall see...

👍️0

georgie18 9月前

LIXT...$4.90...🥳...Hod...

georgie18

Member Level
Re: georgie18 post# 696691

Tuesday, September 09, 2025 11:18:37 AM

Post#
697371
of 697419
LIXT...$4.728...🥳...Hod off my $4 Alert...

georgie18

Member Level
Re: georgie18 post# 397733

Thursday, September 04, 2025 7:51:01 AM

Post#
397742
of 397941
LIXT...$4.67...🥳

georgie18

Member Level
Re: georgie18 post# 696310

Wednesday, September 03, 2025 3:56:59 PM

Post#
696636
of 696690
LIXT...$4.60...🥳...Lets see if we het the Doubl;e Top Breakout here and a run at $5 plus...

georgie18

Member Level
Re: georgie18 post# 397600

Friday, August 29, 2025 11:40:34 AM

Post#
397602
of 397733
LIXT...$4.44...🥳...Looking for $5 Break...

georgie18

Member Level
Re: georgie18 post# 696242

Friday, August 29, 2025 11:18:44 AM

Post#
696306
of 696309
LIXT...$4.32...🥳...Looking for $5 Breakout...

georgie18

Member Level
Re: None

Friday, August 29, 2025 8:18:46 AM

Post#
397578
of 397599
LIXT...$4.00...🥳... https://schrts.co/GKZFBTSZ ...Looking for $5 Breakout...imo...we shall see...

👍️0

georgie18 9月前

LIXT...$4.728...🥳...Hod off my $4 Alert...

georgie18

Member Level
Re: georgie18 post# 397733

Thursday, September 04, 2025 7:51:01 AM

Post#
397742
of 397941
LIXT...$4.67...🥳

georgie18

Member Level
Re: georgie18 post# 696310

Wednesday, September 03, 2025 3:56:59 PM

Post#
696636
of 696690
LIXT...$4.60...🥳...Lets see if we het the Doubl;e Top Breakout here and a run at $5 plus...

georgie18

Member Level
Re: georgie18 post# 397600

Friday, August 29, 2025 11:40:34 AM

Post#
397602
of 397733
LIXT...$4.44...🥳...Looking for $5 Break...

georgie18

Member Level
Re: georgie18 post# 696242

Friday, August 29, 2025 11:18:44 AM

Post#
696306
of 696309
LIXT...$4.32...🥳...Looking for $5 Breakout...

georgie18

Member Level
Re: None

Friday, August 29, 2025 8:18:46 AM

Post#
397578
of 397599
LIXT...$4.00...🥳... https://schrts.co/GKZFBTSZ ...Looking for $5 Breakout...imo...we shall see...

👍️0

georgie18 9月前

LIXT...$4.67...🥳

georgie18

Member Level
Re: georgie18 post# 696310

Wednesday, September 03, 2025 3:56:59 PM

Post#
696636
of 696690
LIXT...$4.60...🥳...Lets see if we het the Doubl;e Top Breakout here and a run at $5 plus...

georgie18

Member Level
Re: georgie18 post# 397600

Friday, August 29, 2025 11:40:34 AM

Post#
397602
of 397733
LIXT...$4.44...🥳...Looking for $5 Break...

georgie18

Member Level
Re: georgie18 post# 696242

Friday, August 29, 2025 11:18:44 AM

Post#
696306
of 696309
LIXT...$4.32...🥳...Looking for $5 Breakout...

georgie18

Member Level
Re: None

Friday, August 29, 2025 8:18:46 AM

Post#
397578
of 397599
LIXT...$4.00...🥳... https://schrts.co/GKZFBTSZ ...Looking for $5 Breakout...imo...we shall see...

👍️0

georgie18 9月前

LIXT...$4.60...🥳...Lets see if we het the Doubl;e Top Breakout here and a run at $5 plus...

georgie18

Member Level
Re: georgie18 post# 397600

Friday, August 29, 2025 11:40:34 AM

Post#
397602
of 397733
LIXT...$4.44...🥳...Looking for $5 Break...

georgie18

Member Level
Re: georgie18 post# 696242

Friday, August 29, 2025 11:18:44 AM

Post#
696306
of 696309
LIXT...$4.32...🥳...Looking for $5 Breakout...

georgie18

Member Level
Re: None

Friday, August 29, 2025 8:18:46 AM

Post#
397578
of 397599
LIXT...$4.00...🥳... https://schrts.co/GKZFBTSZ ...Looking for $5 Breakout...imo...we shall see...

👍️0

georgie18 9月前

LIXT...$4.44...🥳...Looking for $5 Break...

georgie18

Member Level
Re: georgie18 post# 696242

Friday, August 29, 2025 11:18:44 AM

Post#
696306
of 696309
LIXT...$4.32...🥳...Looking for $5 Breakout...

georgie18

Member Level
Re: None

Friday, August 29, 2025 8:18:46 AM

Post#
397578
of 397599
LIXT...$4.00...🥳... https://schrts.co/GKZFBTSZ ...Looking for $5 Breakout...imo...we shall see...

👍️0

georgie18 9月前

LIXT...$4.32...🥳...Looking for $5 Breakout...

georgie18

Member Level
Re: None

Friday, August 29, 2025 8:18:46 AM

Post#
397578
of 397599
LIXT...$4.00...🥳... https://schrts.co/GKZFBTSZ ...Looking for $5 Breakout...imo...we shall see...

👍️0

georgie18 9月前

LIXT...$4.00...🥳... https://schrts.co/GKZFBTSZ ...Looking for $5 Breakout...imo...we shall see...

👍️0

glenn1919 11月前

LIXT.............................................https://stockcharts.com/h-sc/ui?s=LIXT&p=W&b=5&g=0&id=p86431144783

👍️0

INV4 11月前

Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $1.5 Million Registered Direct Offering

July 9, 2025

Spartan Capital Securities, LLC, a premier investment banking firm, is pleased to announce the closing of a $1.5 million registered direct offering for Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT), in which it served as the exclusive placement agent.

Lixte Biotechnology Holdings, Inc., a clinical-stage pharmaceutical company focused on cancer drug development, completed the offering on July 8, 2025. The offering consisted of the sale of an aggregate of 974,026 shares of Common Stock (or Pre-Funded Warrants in lieu thereof). The public offering price per share of Common Stock was $1.54, and $1.53999 per Pre-Funded Warrant, which includes an exercise price of $0.00001.

The Company received gross proceeds of approximately $1.5 million. The net proceeds, together with the Company’s existing cash, will be used for general corporate purposes and working capital.

“This transaction reflects our continued focus on aligning innovative biotech companies with the strategic capital they need to advance breakthrough therapies,” said John Lowry, CEO of Spartan Capital Securities. “We are pleased to support Lixte Biotechnology Holdings, LLC in this important stage of their clinical development and look forward to seeing the impact of their work in the oncology space.”

Lixte was represented by TroyGould PC, while Spartan Capital Securities was represented by Kaufman & Canoles, P.C.

The offering was made pursuant to an effective shelf registration statement on Form S-3 (No. 333-278874) previously filed with and declared effective by the U.S. Securities and Exchange Commission on May 2, 2024. A final prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC and available at www.sec.gov.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Spartan Capital Securities, LLC
Spartan Capital Securities, LLC is a premier full-service investment banking firm offering a comprehensive range of advisory services to institutional clients and high-net-worth individuals. Known for its expertise in capital raising, strategic advisory, and asset management, Spartan Capital delivers tailored solutions to meet clients’ financial goals.

For more information, visit www.spartancapital.com.

About Lixte Biotechnology Holdings, Inc.
Lixte Biotechnology Holdings, Inc. is a clinical-stage pharmaceutical company focused on discovering and developing cancer therapies based on novel biological pathways. Its lead compound, LB-100, a first-in-class PP2A inhibitor, has shown promise in enhancing the effectiveness of chemotherapy and immunotherapy. Clinical trials are currently underway for Ovarian Clear Cell Carcinoma, Metastatic Colon Cancer, and Advanced Soft Tissue Sarcoma.

For more information, visit www.lixte.com.

Contact:
Spartan Capital Securities, LLC
45 Broadway, 19th Floor
New York, NY 10006
investmentbanking@spartancapital.com

https://ih.advfn.com/stock-market/NASDAQ/lixte-biotechnology-LIXT/stock-news/96402861/spartan-capital-securities-llc-serves-as-placemen

$LIXT

👍️0

glenn1919 11月前

LIXT......................................................https://stockcharts.com/h-sc/ui?s=LIXT&p=W&b=5&g=0&id=p86431144783

👍️0

glenn1919 11月前

LIXT..............................................................................................p/m

LIXT MONSTER MOVE COMING IN

👍️0

glenn1919 11月前

LIXT...................................................https://stockcharts.com/h-sc/ui?s=LIXT&p=W&b=5&g=0&id=p86431144783

LIXT.............................................................a/h

LIXT.......................................https://stockcharts.com/h-sc/ui?s=LIXT&p=W&b=5&g=0&id=p86431144783

👍️0

glenn1919 1年前

LIXT............................................https://stockcharts.com/h-sc/ui?s=lixt&p=W&b=5&g=0&id=p86431144783

.................thx..........................

👍️0

tw0122 1年前

$1.06 + 54% ...Company no longer intends to pursue a public offering under the Registration Statement at this time PASADENA, CALIF., Feb. 10, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced that it has filed a request for withdrawal with the Securities and Exchange no longer intends to pursue a public offering under the Registration Statement at this time ommission (the “SEC”) of the Company’s Registration Statement on Form S-1 (No. 333-282781), as amended, originally filed on October 23, 2024 (the “Registration Statement”), as th

👍️0

tw0122 1年前

Early withdrawal has its benefits
$3.29+ 44%

👍️0

glenn1919 2年前

LIXT..................................https://stockcharts.com/h-sc/ui?s=LIXT&p=W&b=5&g=0&id=p86431144783

LIXTE Receives U.S. Patent Issue Notification for Immune Oncology

Another one hit wonder it moved on news

👍️0

Monksdream 2年前

Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc

👍️0

Awl416 2年前

NEW SCIENTIFIC PUBLICATION SHOWS LB-100, LIXTE’S LEAD CLINICAL COMPOUND, CAN FORCE CANCER CELLS TO GIVE UP THEIR CANCER-CAUSING PROPERTIES

👍️0

Awl416 2年前

LIXTE Biotechnology Enters into Exclusive Immune Oncology Patent License Agreement with NINDS and NCI

👍️0

81vette 3年前

Perfectly predictable chart,pullbacks to sma 100% so far

👍️0

81vette 3年前

No debt,current ratio $7.49

👍️0

81vette 3年前

Some $60k-$90k buys,institutional buys starting?12%currently,up2%

👍️0

81vette 3年前

-.02 accumulation Friday,now +.115,loading going on!!

👍️0

81vette 3年前

Not optionable,shares to short dropping

👍️0

81vette 3年前

1.73M float/s.o. 2.25M,12Xs buying vol

July 17, 2023
8:30 am ET
Preclinical Results of LIXTE Biotechnology's Collaboration with Netherlands Cancer Institute Reveal Novel Mechanism by which LIXTE's Lead Clinical Compound LB-100 Enhances Effectiveness of Immunotherapy and Chemotherapy
Globe Newswire

👍️0

CreationGuru10 3年前

Amazing to watch 1.64 to flat same day. SEC sleeps again

👍️0

glenn1919 3年前

LIXT......................................https://stockcharts.com/h-sc/ui?s=LIXT&p=W&b=5&g=0&id=p86431144783

👍️0

TheFinalCD 3年前

LIXT NEWS 1.50'S

MAYBE OFFERING NEXT

WE KNOW THEY NEED IT= $$$$$$$$$$$$$$$$$$$$

👍️0

Invest-in-America 3年前

LIXT: Just more "HYPER-STIMULATION" of the PRICE of their stock!! (HA-HA!!!)

👍️0

TheFinalCD 3年前

1.01 WAS LOD SUCH A SHAME

👍️0

IVANj 3年前

Still no offering… we bouncing here??

👍️0

TheFinalCD 3年前

LIXT 1.34X1.36 could go again, if volume comes in and squeezes= $LIXT here is the technical chart with the inside bar on daily..... i buy the dip never the rip +100 or 200% works better pic.twitter.com/k6IlsHMUIy— Antonio Costa (@ACInvestorBlog) February 8, 2023

👍️0

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Lixte Biotechnology Holdings Inc (LIXT)

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

Lixte Biotechnology Holdings Inc (LIXT) ニュース

The New Bottleneck Isn’t Computing Power — It’s Just Power

From Cancer Drugs to Kilowatts: A NASDAQ Company's Bet on the AI Power Crunch

LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

LIXTE Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

LIXT Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Lixte Biotechnology Holdings Inc (LIXT)

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

Lixte Biotechnology Holdings Inc (LIXT) ニュース

The New Bottleneck Isn’t Computing Power — It’s Just Power

From Cancer Drugs to Kilowatts: A NASDAQ Company's Bet on the AI Power Crunch

LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

LIXTE Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

LIXT Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

無料で登録してください:

広告を削除する